This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Taub, J., Stout, M., Buck, S. et al. Myeloblasts from Doen syndrome children with acute myeloid leukemia have increased in vitro sensitivity to cytosine arabinoside and daunorubicine. Leukemia 11, 1594–1595 (1997). https://doi.org/10.1038/sj.leu.2400747
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2400747
This article is cited by
-
Clinical and biological aspects of myeloid leukemia in Down syndrome
Leukemia (2021)
-
Ontwikkelingen in de diagnostiek en behandeling van leukemie bij kinderen met downsyndroom
Tijdschrift voor Kindergeneeskunde (2009)
-
Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000
Leukemia (2005)
-
AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity
Leukemia (2005)
-
Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93
Leukemia (2004)